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Disease progression of primary pneumonic plague is biphasic, con-
sisting of a preinflammatory and a proinflammatory phase. During
the long preinflammatory phase, bacteria replicate to high levels,
seemingly uninhibited by normal pulmonary defenses. In a coinfec-
tion model of pneumonic plague, it appears that Yersinia pestis
quickly creates a localized, dominant anti-inflammatory state that
allows for the survival and rapid growth of both itself and normally
avirulent organisms. Yersinia pseudotuberculosis, the relatively re-
cent progenitor ofY. pestis, shows no similar trans-complementation
effect, which is unprecedented among other respiratory pathogens.
We demonstrate that the effectors secreted by the Ysc type III secre-
tion system are necessary but not sufficient tomediate this apparent
immunosuppression. Even an unbiased negative selection screen us-
ing a vast pool ofY. pestismutants revealed no selection against any
known virulence genes, demonstrating the transformation of the
lung from a highly restrictive to a generally permissive environment
during the preinflammatory phase of pneumonic plague.
inflammation | pathogenesis
Most lung pathogens induce a measureable inflammatoryresponse within a few hours of infection, but Yersinia pestis is
strikingly different: the first 36 h of infection are characterized by
rapid bacterial replication in the lung without generating appre-
ciable levels of proinflammatory cytokines/chemokines, histolog-
ical changes in infected tissue, or outward disease symptoms. This
process allows the organisms to multiply rapidly before the inflam-
matory response is fully activated, typically too late to control the
infection. Thus, disease progression for primary pneumonic pla-
gue can be subdivided into two distinct phases: an initial prein-
flammatory phase followed by a proinflammatory phase, which is
recapitulated in both mouse and nonhuman primate models of
infection (1–4). The absence of early pulmonary inflammation in
response to Y. pestis could be because of the organisms avoiding
detection by the immune system, a strategy used by many patho-
gens, including Y. pestis (5–7); or, it could be because of the
organisms completely suppressing early innate immune responses,
which has never been observed for bacterial pathogens.
The importance of an early preinflammatory phase is demon-
strated by at least two previous studies. First, Y. pestis exhibits de-
creased replication in the lungs ofmice with a heightened or altered
state of immune activation induced by a latent herpesvirus infection
(8), suggesting that preexisting or early inflammatory responses are
able to partially control andmitigate disease progression. Second, a
Y. pestis mutant lacking YopH, an effector protein of the Yersinia
Ysc type III secretion system (T3SS), is immunostimulatory and
also growth-inhibited during respiratory infection (9). Based on
these studies, we hypothesized that the ability of Y. pestis to actively
suppress early innate immune mechanisms may have a more sig-
nificant role in primary pneumonic plague than any intrinsic
nonstimulatory properties of the bacterium itself. We evaluated
the early consequences of Y. pestis respiratory infection using a
coinfection model of pneumonic plague and discovered that the
organisms are responsible for a rapid and profound modulation of
pulmonary defenses that allows, not only these organisms to pro-
liferate rapidly in the lung, but other microbes as well.
Results and Discussion
Pulmonary trans-Complementation of Avirulent Mutants by Wild-
Type Y. pestis. We designed a series of in vivo coinfection exper-
iments to test the idea that Y. pestis produces a dominant im-
munosuppressive state in the lung. Using a genetically marked
wild-type strain [ΔlacZ mutant of Y. pestis CO92 (10) -YP160]
(Fig. S1) to quantitatively measure competition, we coinfected
C57BL/6J mice with a Y. pestis ΔyopH strain to see if the
immunostimulatory response to the mutant could be “sup-
pressed” by the wild-type bacteria. After intranasal inoculation
of a 1:1 mixture of wild-type and ΔyopH strains, we observed that
wild-type bacteria were able to almost fully restore the in vivo
replication defect of a coinfecting ΔyopH mutant (Fig. 1A).
These results were somewhat unexpected based on previously
published work with closely related Yersinia pseudotuberculosis,
from which Y. pestis has rather recently evolved (11). Respiratory
coinfection with wild-type Y. pseudotuberculosis is unable to rescue
bacterial replication defects of individual Yop mutants (12). All
pathogenic Yersinia harbor a nearly identical Ysc T3SS, which
directly injects into host cells a number of cytotoxins or effector
proteins (Yops) that inhibit bacterial phagocytosis and other in-
nate immune processes (13). Therefore, Y. pestis-specific evolu-
tionary adaptions beyond the Ysc-Yop T3SS have produced a
pathogen that is not only substantially more virulent than its im-
mediate ancestor, but also able to compensate for the virulence
defects of a coinfecting attenuated strain. We next tested the ex-
tent to which fully virulent Y. pestis could compensate for defi-
ciencies of other attenuated isogenic mutants. In these respiratory
coinfections, wild-type Y. pestis could also compensate for (or
“trans-complement”) the major virulence defects of bothΔpla and
pCD1− mutants (Fig. 1A), restoring four to six logs of bacterial
growth capacity during the first 48 hours postinfection (hpi).
The profound impact of the presence of wild-type Y. pestis on
the fate of pCD1−mutants was particularly surprising, because the
pCD1 plasmid (commonly called the Yersinia “virulence plasmid”)
encodes the entire Ysc T3SS and its virulence-associated Yop
effectors. In our intranasal model of infection, pCD1−mutants are
severely attenuated (3), unable to proliferate in the lung, and
successfully cleared by innate immunemechanisms. Therefore, we
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examined the impact of wild-type Y. pestis on coinfecting pCD1−
mutants in more detail. Although the kinetics of bacterial repli-
cation progressed as expected during pulmonary infection with
either wild-type bacteria or pCD1− mutants when inoculated in-
dividually (3), growth of the pCD1− strain increased substantially
when coinoculated at a 1:1 ratio with wild-type Y. pestis. As the
infection progressed, this trans-complementation of pCD1− mu-
tant growth continued to increase, reaching six to eight logs at 60
hpi (Fig. 1B). Although we normally do not see pCD1− mutants
spreading to the spleen of mice following a pulmonary infection,
we were able to detect 104–106 pCD1− bacteria in the spleens of
mice coinfected with wild-type Y. pestis at 60 hpi (Fig. 1C).
Trans-Complementation Following Subcutanteous Inoculation. The
lung alveoli play a critical role in respiratory gas exchange, and
inflammation-induced edema can lead to severe lung distress.
Thus, the lung has many innate immune mechanisms, including
the mucociliary escalator and alveolar macrophages, which allow
for the rapid clearance of inhaled microorganisms and foreign
particles (14). These systems most likely aid in the elimination of
Y. pestis pCD1− mutants, which are cleared without producing
any appreciable inflammatory response from the host (3). To
determine whether unique aspects of the lung’s physiology con-
tribute to the ability of Y. pestis to trans-complement avirulent
isogenic strains, we also examined the kinetics of bacterial rep-
lication in a subcutaneous inoculation model that mimics the
route of infection and lymphatic dissemination seen in bubonic
plague (Fig. 1D and E). In the draining cervical lymph nodes,
pCD1− mutants were able to replicate four to five logs more by
48 hpi when coinfected with wild-type bacteria than when
infected individually (Fig. 1D). Wild-type bacteria also facilitated
the dissemination of pCD1− mutants to the spleens of animals
coinfected by the subcutaneous route (Fig. 1E). These results are






























































































































Fig. 1. Wild-type Y. pestis is able trans-complement avirulent isogenic strains of Y. pestis. (A) Individual intranasal infections (white bars) for ΔyopH (YP373),
Δpla (YP102), or pCD1− (YP6) mutants or matched coinfections (gray bars) with wild-type Y. pestis in C57BL/6J mice. CFU per lung were determined at 48 hpi
using BHI agar plates containing X-Gal. All CFU differences between individual infections and corresponding coinfections (A–E, all time points) are statistically
significant (P ≤ 0.01; unpaired t test). (B–E) Kinetics of infection for pCD1− mutants (YP6, red), wild-type (YP160, black), and a 1:1 coinfection of pCD1−
mutants (blue) and wild-type Y. pestis (green) infected intranasally (B and C) or subcutaneously (D and E). CFU per tissue were determined at various time
points of infection for lungs (B), spleen (C and E), and cervical lymph nodes (D). Each bar (A) or point (B–E) represents the mean CFU recovered from five mice.
The limit of detection is represented by a dotted line. Data and statistical conclusions are representative of at least two independent experiments. Error bars
represent SEM for the bar graph and SD from the mean for line graphs.
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occurring in the spleens (but not the livers) of mice inoculated
intravenous with Y. pestis KIM5 (pgm−) and an isogenic ΔyopM
mutant (15). Although trans-complementation following sub-
cutaneous or intravenous infection are not as pronounced as that
seen during pulmonary coinfection, all of these results suggest a
dominant immunosuppressive effect of wild-type bacteria and
demonstrate that the physiology of different organ systems may
determine the extent of trans-complementation.
Localization and Timing of trans-Complementation. In pneumonic
plague, the earliest stages of inflammation appear as distinct foci,
and this is also wheremost of themultiplying bacteria are observed
(3). We wondered whether the trans-complementation effect is
similarly localized, or whether it reflects immunosuppression of
the entire pulmonary compartment. Our first indication came
from coinfection experiments in which we varied the inoculum
ratios of avirulent to virulent Y. pestis (Fig. 2A). After the first 24
hpi, the numbers of pCD1− mutants never exceeded the numbers
of wild-type Y. pestis and were maintained at a constant ratio of 1
pCD1−:10 wild-type, regardless of the initial ratio in the inoculum.
This tight regulation of proliferation of pCD1− mutants by wild-
type Y. pestis suggests that trans-complementation may reflect
more of a local control rather than a global effect throughout the
lung. In agreement with these observations were the results of
pulmonary coinfections with gfp-expressing pCD1− mutants and
rfp-expressing wild-type Y. pestis (1:1). Colocalization of the green
and red fluorescence revealed replicating pCD1− mutants only in
close association with wild-type Y. pestis in inflammatory foci, but
not in regions of the lung were wild-type bacteria were not present
(Fig. 2B). These data suggest that during the initial stages of in-
fection, an avirulent mutant’s proximity to fully virulent Y. pestis
determines whether it will proliferate or be eliminated by the
lung’s innate immune mechanisms.
Trans-Complementation Is Unique to Y. pestis. The ability of a mi-
croorganism to suppress the lung’s innate immune system, ef-
fectively compensating for mutants missing a variety of virulence
factors, is unprecedented among bacterial pathogens. In contrast
to the trans-complementation phenomenon we have documented
with fully virulent Y. pestis (Fig. S2), wild-type Y. pseudotuber-
culosis IP2666c was unable to trans-complement isogenic
mutants lacking the Yersinia virulence plasmid (designated pYV
in Y. pseudotuberculosis) or pCD1− mutants of Y. pestis during
pulmonary coinfection (Fig. 3A) (12). Wild-type Y. pseudotu-
berculosis IP32953, which causes a lung infection with nearly the
same bacterial burden as Y. pestis, was also unable to trans-
complement an isogenic pYV− strain (Fig. S3A). Similarly, wild-
type Klebsiella pneumoniae, which can also cause an acute bac-
terial pneumonia, failed to significantly trans-complement iso-
genic strains that have mutations in predominant virulence genes
(such as a ΔcpsBmutant, which lacks the polysaccharide capsule)
or pCD1− mutants of Y. pestis (Fig. 3B) (16). Conversely, virulent
Y. pestis was able to significantly trans-complement ΔcpsB K.
pneumoniae and fully trans-complement pYV− Y. pseudotuber-
culosis IP2666c (Fig. 3C) during pulmonary coinfections. In ad-
dition, we have observed that pulmonary infection with wild-type
Y. pestis, but not pCD1− mutants, frequently leads to secondary
bacterial infections. These bacteria, most likely introduced dur-
ing the process of intranasal inoculation, can reach levels of 107
bacteria/lung at 60 hpi in wild-type-infected mice (Fig. 3D).
Some Yop effector proteins secreted by the plasmid-encoded
Ysc T3SS are known to have anti-inflammatory mechanisms, and
the Ysc-Yop system is required for all three Yersinia species to
cause mammalian infection. Because we observed trans-com-
plementation for Y. pestis but not Y. pseudotuberculosis, even
when growing to comparable levels in the lung, we tested
whether this could be because of Y. pestis-specific evolutionary
changes in the Ysc-Yop T3SS encoded on the virulence plasmid.
We exchanged pCD1 in Y. pestis with its corresponding Y.
pseudotuberculosis virulence plasmid (pYV), and this Y. pestis
pCD1− pYV+ strain still trans-complemented a Y. pestis pCD1−
mutant (Fig. S3B). These data suggest that although the Ysc-
Yop T3SS is necessary for a productive infection and for trans-
complementation, subtle evolutionary adaptions to the Ysc-Yop
system during the evolution of Y. pestis are not solely responsible
for the trans-complementation effect.
Scope of trans-Complementation. Finally, we wanted to use a broad,
unbiased approach to evaluate the scope of trans-complementa-
tion by Y. pestis. Negative selection screens are often used to
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Fig. 2. Relative numbers and distribution of virulent and avirulent Y. pestis
during pulmonary coinfections. (A) Kinetics of infection for C57BL/6J mice
intranasally infected with varying ratios of pCD1− mutants (YP6) and wild-
type Y. pestis (YP160) [10:1 (black), 1:1 (blue), and 1:10 (orange) pCD1−: wild-
type]. CFU per lung were determined at various time points of infection.
Each point represents the mean CFU recovered from five mice. Each ratio
maintained a 1:10 mutant: wild-type ratio after 24 hpi. There were no sta-
tistically significant differences between the CFU of pCD1− mutants between
any given ratio at each time point (P > 0.05; unpaired t test). The limit of
detection is represented by a dotted line. Data and statistical conclusions are
representative of at least two independent experiments. Error bars repre-
sent SD from the mean. (B) Mice were coinoculated intranasally with gfp-
expressing pCD1− mutants (BGY19) and rfp-expressing wild-type Y. pestis
(YP337). At 48 hpi, lungs were fixed and cryosectioned. Fluorescence
deconvolution images were generated from 10-μm sections. The image is
representative of multiple independent experiments. (Scale bar, 10 μm.)









identify and confirm virulence-associated genes in animal models
of infection (17). These screens rely on the fundamental as-
sumption that during an infection with a pool of isogenic mutants,
it will be possible to select against and subsequently identify single
attenuated mutants. We used the microarray-based negative se-
lection technique known as transposon site hybridization (TraSH)
(18) to comprehensively characterize trans-complementation
during experimental pneumonic plague. The typical expectation
of TraSH is that it should reveal in vivo selection against mutants
that lack key virulence factors; however, our Y. pestis coinfection
results predicted that we may not observe any in vivo selection
against individual attenuated mutants in a mixed pool. Re-
markably, all known Yersinia virulence genes implicated in
pneumonic plague either directly or indirectly showed less than
a twofold negative selection in vivo (Table 1). In contrast, nega-
tive selection screens have been used to identify and confirm
virulence determinants in other lung pathogens, including
Pseudomonas aerginosa, Burkholderia pseudomallei, Burkholderia
cenocepacia, Streptococcus pneumoniae, and Mycobacterium tu-
berculosis (19–24).
These observations suggest that Y. pestis is able to create a
dominant, localized anti-inflammatory state early during lung in-
fection, and this establishes a unique protective environment that
even allows nonpathogenic organisms to prosper. Y. pestis rather
recently evolved from a food-borne pathogen (Y. pseudotubercu-
losis) to become an arthropod-borne pathogen, and this is thought
to have strongly favored the coevolution of increased virulence for
mammals (25). Poor arthropod vector competence imposed the
need to generate very high levels of bacteremia from very few
inoculating bacteria to efficiently maintain the natural route of
transmission between arthropods and their mammalian hosts.
Thus, an early anti-inflammatory state at the site of infection
would be biologically advantageous in ensuring that Y. pestis can
replicate unfettered until its numbers are sufficient for trans-
mission. When finally recognized by the immune system, the
bacteria are at such a high titer that they trigger an overly robust
inflammatory response. In the case of a lung infection, the switch
from unrestricted bacterial growth to overwhelming inflammation
results in rapid decline in pulmonary function and the corre-
sponding fatalities associated with primary pneumonic plague.
Materials and Methods
Reagents, Bacterial Strains, and Culture Conditions. All chemicals, unless oth-
erwise noted, were obtained from Sigma-Aldrich. Table S1 provides a de-
scription of bacterial strains, plasmids and oligonucleotides used in this study.
The fully virulent, wild-type Yersinia pestis strain CO92 (YP3) and its plasmid
cured derivative CO92 pCD1− (YP6) were obtained from the US Army, Fort
Detrick, MD (Table S1). The presence or absence of pCD1, pMT1, pPCP1, and
the pgm locus was confirmed by PCR for each strain before use. Y. pestiswere
Fig. 3. Specificity of bacterial trans-complementation during pulmonary in-
fection. (A) Y. pseudotuberculosis, which harbors the same T3SS as Y. pestis, is
unable to trans-complement in the lung. Individual intranasal infections
(white bars) for pYV−Y. pseudotuberculosis IP2666mutants (BGY39), pCD1−Y.
pestismutants (BGY14-1), andwild-typeY. pseudotuberculosis IP2666 (BGY30)
and matched coinfections (gray bars) with wild-type Y. pseudotuberculosis
IP2666 in C57BL/6J mice (all differences between individual and co-infections
were not significant, P > 0.05; unpaired t test). (B) K. pneumoniae, another
pulmonary pathogen, is unable to trans-complement in the lung. Individual
intranasal infections (white bars) for ΔcpsB K. pneumoniae mutants (VK060),
pCD1− Y. pestis mutants (BGY14-1) and wild-type K. pneumoniae (KPPR1),
and matched coinfections (gray bars) with wild-type K. pneumoniae in
C57BL/6J mice (all differences between individual and co-infections were not
significant, P > 0.05; unpaired t test). (C) Y. pestis is able to trans-comple-
ment avirulent strains of other pathogens. Individual intranasal infections
(white bars) for ΔcpsB K. pneumoniae mutants (VK060), pYV− Y. pseudo-
tuberculosis IP2666 mutants (BGY38) and wild-type Y. pestis (YP160), and
matched coinfections (gray bars) with wild-type Y. pestis in C57BL/6J mice
(all differences between individual and co-infections were significant, P ≤
0.001; unpaired t test). (D) Wild-type Y. pestis creates a permissive environ-
ment that allows nonpathogenic bacteria to proliferate in the lung. Kinetics
of infection for pCD1− mutants (red) and wild-type Y. pestis (black) in C57BL/
6J mice infected intranasally. CFU per lung were determined at various time
points of infection on both BHI (Y. pestis) and BHI-MOX agar plates (non-Y.
pestis bacteria). Each bar (A–C) or point (D) represents the mean CFU re-
covered from five mice. The limit of detection is represented by a dotted
line. Data and statistical conclusions are representative of at least two in-
dependent experiments. Error bars represent SEM for bar graphs and SD
from the mean for line graphs.
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routinely grown on brain-heart infusion (BHI) agar (Difco Laboratories) at
26 °C for 2–3 d. Liquid cultures of Y. pestis were grown in BHI broth (Difco
Laboratories) at 26 °C for 6–8 h before being diluted to an OD620 of 0.05–0.1
in 10 mL of BHI supplemented with 2.5 mM CaCl2 in a 125-mL Erlenmeyer
flask and grown overnight at 37 °C or 26 °C on a shaker set at 250 rpm.
Y. pseudotuberculosis IP2666c and derivatives were obtained from the lab-
oratory of Joan Mecsas (Tufts University, Boston, MA). Y. pseudotuberculosis
IP32953 and K. pneumoniae subspecies pneumoniae and derivatives were
obtained from the laboratory of Virginia Miller (University of North Carolina
at Chapel Hill).Y. pseudotuberculosis strains were routinely grown at 26 °C on
LB agar for 2 d or in LB broth for 12–14 h. K. pneumoniae strains were grown
at 37 °C for 10–12 h on LB agar or in LB broth. For animal infections, Y.
pseudotuberculosis andK. pneumoniaewere grown in BHI broth as described
above for Y. pestis. Media were supplemented with ampicillin (100 μg·mL−1),
kanamycin (50 μg·mL−1), polymyxin B (25 μg·mL−1), X-Gal (40 μg·mL−1), or
magnesium oxalate (MOX; 20 mM MgCl2 and 20 mM Na2C2O4) as required.
Chelation of calcium ions by MOX causes a “low calcium response” restriction
of 37 °C growth of Y. pestis harboring pCD1.
Construction of Y. pestis Deletion Strains. Y. pestis deletion strains (YP373 and
BGY14-1) were constructed using a modified lambda red recombination
system described previously by Lathem et al. (6). Briefly, 500 bp upstream and
500 bp downstream of each gene were amplified by PCR using the oligonu-
cleotides yopH 3′+500 and P1yopH 3′3 (yopH upstream region), yopH 5′-500
and P4yopH 5′1406 (yopH downstream region), YplacZUP-F and YplacZUP-R
(lacZ upstream region), and YplacZDN-R and YplacZDN-F (lacZ downstream
region). The respective PCR products were gel-purified and combined in
splicing by overhang extension (SOE)-PCR reactions with a kanR cassette
flanked by FRT sites, which had previously been applied from the plasmid
pKD13 (26). Oligonucleotides yopH 3′+500, yopH 5′-500, YplacZUP-F and
YplacZDN-R were used in their respective SOE-PCR reactions. The resulting
PCR products (yopH-FRT-KanR-FRT-yopH and lacZ-FRT-KanR-FRT-lacZ) were
gel-purified and transformed into YPI54 or BGY0, Y. pestis strains carrying
pWL204, which had been grown at 26 °C in the presence of 10 mM arabinose
to induce the lambda red recombinase genes. Putative recombinants were
selected on BHI plates containing kanamycin. Recombinants were passaged
on BHI plates containing 5% sucrose to cure pWL204. The kanR cassette in the
ΔyopH mutant strain was resolved by transforming the strain with pSkippy,
a tetS derivative of pFLP3 (27) carrying the FLP recombinase and sacB genes,
and growing the strain overnight at 26 °C in the presence of 1 mM isfopropyl-
β-D-thiogalactopyranoside. The overnight cultures were diluted and plated
on BHI plates containing 5% sucrose to cure pSkippy. KanS and ampS
recombinants were selected and in-frame deletions of the target gene were
verified by PCR. For each strain, the presence of all of the major virulence loci
(pCD1+, pMT1+, pPCP1+ and pgm+) was confirmed by PCR.
Construction of Y. pseudotuberculosis IP2666c Strains. Y. pseudotuberculosis
IP2666c pIB1− (BGY39) was constructed by passaging the Y. pseudotuber-
culosis IP2666c pIB1+ (LL-89) on BHI-MOX agar plates and selecting large
colony variants, indicating the loss of the virulence plasmid pIB1. The loss
of pIB1 was confirmed using PCR. Y. pseudotuberculosis pYV− lacZ::kanR
(BGY38) was constructed via lambda red recombination as described above,
using the same primers to amplify the regions adjacent to lacZ.
Animals.All animal studies were approved by the University of North Carolina
in Chapel Hill Office of Animal Care and Use protocol #09–057.0-A or the
Washington University Animal Studies Committee protocol #20060154.
Pathogen-free, 6- to 8-wk-old C57BL/6J mice were obtained from The Jack-
son Laboratory. Mice were housed in a Techniplast Isocage containment
system during all experiments. Mice were provided with food and water ad
libitum and maintained on a 12-h light/12-h dark cycle at 25 °C and 15%
humidity. Bacteria were grown in BHI broth as described above, and the
optical density (OD620) of the culture was used to estimate bacterial con-
centrations. Actual bacterial concentrations were determined by plating
serial dilutions of the inoculum on BHI or LB agar plates. The bacteria were
then washed in endotoxin-free PBS and maintained at 37 °C (intranasal in-
fection) or 26 °C (subcutaneous infection) before inoculation, unless other-
wise indicated. Mice were anesthetized with a ketamine/xylazine solution
(50 mg·kg−1/10 mg·kg−1) and inoculated with 20 μL or 100 μL of bacteria in
PBS via an intranasal or subcutaneous route, respectively. Animals were
monitored twice daily and killed with an overdose of sodium pentobarbital
(180 mg·kg−1) at designated timepoints, or when the animal was clearly
moribund.
Animal Infections. For both the individual infection and coinfection experi-
ments, groups of four to five mice were inoculated intranasally with 1 × 104
CFU of Y. pestis, Y. pseudotuberculosis, or K. pneumoniae for individual and
coinfections with equal ratios (1 pCD1−:1 wild-type). In experiments with
varying ratios (1 pCD1−:10 wild-type, 1 pCD1−:1 wild-type and 10 pCD1−:1
wild-type), we inoculated with1 × 105 CFU of Y. pestis. Groups of four to five
mice were inoculated subcutaneously in the front neck with 1,000 CFU of Y.
pestis for both individual and coinfections. For both Y. pestis and Y. pseu-
dotuberculosis, lacZ mutants (10, 12) were designated as our “wild-type”
strain, and blue/white screening was used to differentiate between coino-
culated strains. Bacterial organ burdens were determined by plating bacteria
on BHI or LB agar containing X-Gal for experiments involving multiple Y.
pestis or Y. pseudotuberculosis strains. For experiments involving K. pneu-
moniae, organ burdens were determined using LB agar with kanamycin
(selection mutant) or without kanamycin. For mixed species experiments [Y.
pseudotuberculosis or K. pneumoniae with Y. pestis pCD1− lacZ::kanR
(BGY14-1)], organ burdens were determined using BHI agar with kanamycin
(Y. pestis pCD1− mutant selection) or without kanamycin. At the indicated
times postinoculation, mice were killed, lungs and spleen (after intranasal
inoculation) or lymph nodes, spleen, and lungs (after subcutaneous in-
oculation) were surgically removed, weighed, and homogenized in 0.5 mL
PBS. Serial dilutions for each organ were plated on BHI or LB agar as in-
dicated above. Bacterial burdens are reported as CFU/tissue.
Histopathology. Groups of three to five mice were inoculated intranasally
with 1 × 104 CFU of a 1:1 ratio of Y. pestis [1 gfp-expressing pCD1− (BGY23):1
rfp-expressing wild-type (YP337)]. Mice were killed at 48 hpi with an over-
dose of sodium pentobarbital, and their lungs were inflated with 10%
neutral buffered formalin via tracheal cannulation. The lungs were then
removed from the animal and fixed for 96 h in 10% neutral buffered for-
malin. All samples were negative for bacterial growth before being removed
from the BSL-3 facility. The lungs were washed twice in PBS for 1 h and then
in PBS-30% sucrose for 24 h. Frozen sections were generated by freezing the
lungs in optimal cutting temperature compound on dry ice for 20 min and
then at −80 °C overnight. Ten-micrometer sections were mounted with Pro-
Long Gold (Invitrogen) and viewed under an Olympus BX60 fluorescence
microscope. iVision software v. 4.0.0 (BioVision Technologies) was used for
z-stack image collection and deconvolution.
Construction of Transposon Mutant Library. The transposon mutant library
was generated using the Himar1-based transposon system encoded on
pPP47, which was constructed in multiple steps using the phagemid
ϕMycoMarT7 (28) and pTnMod-RKm (29). Briefly, pTnMod-RKm was diges-
ted with BglII, and blunt ends were generated using Klenow treatment. The
resulting fragments were then digested with EcoRI, and the fragment cor-
responding to the RP4 origin of transfer was ligated to the Himar1 trans-
poson, which was previously amplified from ϕMycoMarT7 using the
oligonucleotides TraSHHimarIR5′(PmeI/AscI) and TraSHIR3′(MfeI), and
transformed into Escherichia coli S17. The Himar1 transposon contains an
R6K origin of replication, a KanR cassette and flanking T7 promotors ori-
ented so as to promote transcription into the chromosomal DNA. The Tn5
promotor region (pTnMod-RKm) and the Himar1 transposase (ϕMycoMarT7)
were independently amplified using the oligonucleotides TraSH-TnMod-
PromII and TraSH Tase-PromII, and TraSHTase-PromIIGC and TraSH5′Tase
(AscI), respectively, and then joined together by SOE-PCR. The resulting PCR
products were cloned into the AscI site adjacent to the Himar1 transposon to
create pPP47. E. coli S17 carrying pPP47 were mated with wild-type Y. pestis
Table 1. TraSH screen reveals global trans-complementation
during primary pneumonic plague
Gene Reference Fold-representation P value
yopH (31) −1.85 0.016
yopD (13) −1.33 0.0029
pla (6) −1.32 0.076
lcrF (32) −1.26 0.030
ail (33) −1.88 0.056
psn (34) −1.54 0.072
Representatives of known Yersinia virulence genes required for primary
pneumonic plague and their representation in the in vivo mutant pool
(TraSH probes for the mutant library 48 h postintranasal inoculation in
C57BL/6 mice) compared with the in vitro pool (TraSH probes for the mutant
library). Negative values indicate an underrepresentation in the output pool.









and plated on BHI agar containing kanamycin for Y. pestis selection and
polymyxin B for E. coli counter selection. Southern blot analysis of 20 ran-
domly selected colonies indicated that each mutant contained a single
transposon insertion. There were ∼2.5 × 105 mutants in the transposon
mutant library used in the subsequent experiments.
Transposon Site Hybridization. The transposon mutant library was used in
animal experiments to identify genes that are required for infection during
primarypneumonicplague. Theprotocolsused in theseexperimentshavebeen
describedpreviously (18, 28). Briefly, 10micewere inoculated intranasallywith
2 × 105 CFU of the transposonmutant library. The in vitro pool was generated
by replating the library on BHI agar. At 48 hpi, the mice were killed, and a
subset of the surviving bacteria (5 × 105 CFU) was recovered from lung
homogenates by plating on BHI agar plates containing kanamycin. Genomic
DNAwas isolated from each pool, andmodified TraSHprobeswere generated
as previously described (28). Briefly, genomic DNA was partially digested with
HinPI and MspI. DNA fragments (500–2,000 bp) were gel-purified and ligated
to adaptors generated with the oligonucleotides TraSH-Probe-Lig1 and
TraSH-Probe-Lig2. Ligated DNA was used as a template in two separate PCR
reactions containing the oligonucleotide TraSH-Probe-PCRadaptor and either
TraSH-Probe-PCRtrans1 or TraSH-Probe-PCRtrans1. Gel-purified PCR products
(250–500 bp) were used template for in vitro T7 transcription reactions
(Ambion). Template DNA was digested with TurboDNase (Ambion), and the
RNAwas purified and used to generate ds-cDNA (Invitrogen) with the primers
TraSH-Probe-PCRadaptor and TraSH-cDNA-2nd-strand. The in vitro and in vivo
probes were then labeled with Cy3 or Cy5 and cohybridized to the array as
described previously (3). Probes were generated from each pool three times
and analyzed on duplicate microarrays for a total of six microarray hybrid-
izations per experiment. Two independent experiments were performed,
yielding consistent results. The arrays were scanned following hybridization
and analyzed using Partek Genomics Suite (Partek Inc). Data for each exper-
iment were analyzed using multiple testing correction after three-way
ANOVA and reported as the fold-representation in the in vivo pool compared
with the in vitro pool, where negative values indicate a relative under-
representation in the in vivo pool. This approach was technically validated by
defining the genes required for Y. pestis growth on BHI agar plates, similar to
validation performed previously for other organisms (30).
Statistical Analyses. An unpaired Student t test was used to determine the
statistical significance (P ≤ 0.05) between individual and coinfection exper-
iments. If the variance between datasets was statistically significant, the
data were transformed (log-based transformation) to achieve normality
between datasets before calculating their significance. All statistical analyses
were calculated using Prism v4.0c software (GraphPad Software).
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